Inducibility of UDP-glucuronosyltransferase 1As by beta-naphthoflavone in HepG2 cells. 2006

Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Okayama 700-8530, Japan.

UDP-glucuronosyltransferases (UGTs) are conjugation enzymes, which are regulated in a tissue-specific manner by endogenous and environmental factors. In this study, we focused on UGT1A isoforms (UGT1A1, UGT1A6 and UGT1A9), mainly expressed in the human liver, and examined the inducibility of UGT1As by beta-naphthoflavone (BNF) in human hepatoma HepG2 cells. The cells were pretreated for 72 h with BNF at concentrations of 25, 50 and 100 microM. 7-Ethyl-10-hydroxycamptothecin (SN-38) glucuronidation, used as a probe for UGT1A1, showed sigmoidal kinetics with a Hill coefficient (n) of 1.2-1.3 in control and BNF-pretreated HepG2 cells. The Vmax values were significantly increased 3.6- to 4.3-fold by BNF, whereas there was no significant change in the S50 values by BNF at any concentration examined. On the other hand, 4-methylumbelliferone (4-MU) glucuronidation as a probe for UGT1A6 and UGT1A9 in the control and BNF-pretreated HepG2 cells exhibited a biphasic kinetic pattern. Although Km1 values for the low-Km phase were similar between the control and BNF-pretreated HepG2 cells, Km2 values for the high-Km phase of BNF-pretreated HepG2 cells were reduced to 54-69% of control HepG2 cells. The values of Vmax1 and Vmax2 for the low- and high-Km phases, respectively, were significantly increased 1.9- to 2.6-fold by BNF at 25 and/or 50 microM but not 100 microM. With respect to Vmax (Vmax1 and Vmax2) and Vmax/Km (Vmax1/Km1 and Vmax2/Km2), the values were significantly increased 2.0- to 3.2-fold by BNF at all concentrations examined. Furthermore, real-time reverse transcription polymerase chain reaction using TaqMan probes demonstrated that BNF concentration-dependently induced mRNA levels of UGT1A1 but not UGT1A6 or UGT1A9 in HepG2 cells (1.3- to 6.0-fold). These results suggest that the inducibility of UGT1A isoforms in HepG2 cells by BNF is different from other aryl hydrocarbon receptor agonists previously reported, and should provide useful information for the prediction of drug-drug interactions and toxicological assessment of environmental chemicals.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090264 UDP-Glucuronosyltransferase 1A9 A PPAR alpha and PPAR gamma target gene. The enzyme plays an important role in elimination and DETOXIFICATION of drugs, XENOBIOTICS, and metabolizing endogenous compounds, including CATECHOLESTROGENS and FIBRATES. UDP-Glucuronosyltransferase, UGT1A9,UGT1A9 Protein,Uridine Diphosphate-Glucuronosyltransferase 1A9,1A9, UDP-Glucuronosyltransferase,1A9, Uridine Diphosphate-Glucuronosyltransferase,Protein, UGT1A9,UDP Glucuronosyltransferase, UGT1A9,UGT1A9 UDP-Glucuronosyltransferase
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014453 Glucuronosyltransferase A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17. Glucuronyltransferase,UDP Glucuronosyltransferase,17 beta-Hydroxysteroid UDP-Glucuronosyltransferase,4-Nitrophenol-UDP-Glucuronosyltransferase,7-Hydroxycoumarin UDP Glucuronyltransferase,Androsterone UDP-Glucuronosyltransferase,Bilirubin UDP-Glucuronyltransferase,Estrogen UDP-Glucuronosyltransferase,Estrone Glucuronyltransferase,Glucuronic Transferase,Morphine Glucuronyltransferase,UDP Glucuronyl Transferase,UDP-Glucuronic Acid 3-O-beta-D-Galactosyl-D-Galactose Glucuronosyltransferase,p-Nitrophenyl UDP-Glucuronosyltransferase,17 beta Hydroxysteroid UDP Glucuronosyltransferase,4 Nitrophenol UDP Glucuronosyltransferase,7 Hydroxycoumarin UDP Glucuronyltransferase,Androsterone UDP Glucuronosyltransferase,Bilirubin UDP Glucuronyltransferase,Estrogen UDP Glucuronosyltransferase,Glucuronosyltransferase, UDP,Glucuronyl Transferase, UDP,Glucuronyltransferase, 7-Hydroxycoumarin UDP,Glucuronyltransferase, Estrone,Glucuronyltransferase, Morphine,Transferase, Glucuronic,Transferase, UDP Glucuronyl,UDP Glucuronic Acid 3 O beta D Galactosyl D Galactose Glucuronosyltransferase,UDP Glucuronyltransferase, 7-Hydroxycoumarin,UDP-Glucuronosyltransferase, 17 beta-Hydroxysteroid,UDP-Glucuronosyltransferase, Androsterone,UDP-Glucuronosyltransferase, Estrogen,UDP-Glucuronosyltransferase, p-Nitrophenyl,UDP-Glucuronyltransferase, Bilirubin,p Nitrophenyl UDP Glucuronosyltransferase
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D019324 beta-Naphthoflavone A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. (Proc Soc Exp Biol Med 1994 Dec:207(3):302-308) 5,6-Benzoflavone,5,6 Benzoflavone,beta Naphthoflavone

Related Publications

Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
March 2012, Basic & clinical pharmacology & toxicology,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
August 1997, Biochimica et biophysica acta,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
October 2012, Chemosphere,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
December 1998, European journal of biochemistry,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
September 2017, Molecular pharmaceutics,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
May 2015, Drug metabolism and disposition: the biological fate of chemicals,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
June 2024, Journal of ethnopharmacology,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
June 2009, The Journal of pharmacology and experimental therapeutics,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
January 2002, Nihon eiseigaku zasshi. Japanese journal of hygiene,
Nobumitsu Hanioka, and Nobuhiko Obika, and Masuhiro Nishimura, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Keita Saito, and Kimio Kiryu, and Shinsaku Naito, and Shizuo Narimatsu
January 1998, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!